Adtx stock forecast

View the latest Aditxt Inc. (ADTX) stock price, news, historica

The Aditxt Inc (ADTX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $125.29, representing a +3,607% increase from the current price of $3.38. The highest analyst price target is $236.91, and the lowest is $13.66. Find the latest ContraFect Corporation (CFRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...3 Wall Street research analysts have issued 12-month target prices for Aptinyx's stock. Their APTX share price targets range from $0.50 to $0.50. On average, they expect the company's share price to reach $0.50 in the next year. This suggests a possible upside of 669.2% from the stock's current price.

Did you know?

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the offering are expected to be $10.0 million, prior to deducting placement agent’s ...This predictive model assumes future stock price movements can be determined based on the difference between the stock price and the EMA12. The model cosiders three possible regimes: price crossed EMA12 from bellow (CB), price crossed EMA12 from above (CA), price remains above EMA12 (A) and price remains below EMA12 (B).According to one analyst, the rating for ADTX stock is "Strong Buy" and the 12-month stock price forecast is $61.0. Price Target $61.0 ( 1,642.86% upside) Analyst …Find the latest SEC Filings data for Aditxt, Inc. Common Stock (ADTX) at Nasdaq.com.Find real-time MSFT - Microsoft Corp stock quotes, company profile, news and forecasts from CNN Business.Jun 30, 2020 · The shares of the Company’s common stock will separate from the unit and immediately begin trading on the Nasdaq Capital Market on June 30, 2020 under the ticker symbol “ADTX”. A high-level overview of Aditxt, Inc. (ADTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Aditxt (NASDAQ:ADTX) stock rose ~7% on Friday after the company said its program Adimune started the GMP manufacturing of immunotherapy drug candidate ADI-100 for its first-in-human trials in H2 2023.What is Aditxt's Market Cap? ( NASDAQ: ADTX) Aditxt 's market cap is $2.03M, as of Oct 13, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Aditxt 's market cap is calculated by multiplying ADTX 's current stock price of $10.65 by ADTX 's total outstanding shares of 190,268.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...ADTX Stock Sentiment Analysis Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very …Dec 1, 2023 · Aditxt Stock Forecast All Analysts Top Analysts ADTX's stock price has decreased by -94.65% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for Aditxt stock is $61, which predicts an increase of 1,694.12%. Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate Jul 08. Aditxt, Inc., Annual General Meeting, Jun 24, 2022 May 12. ... Earnings vs …Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered ...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.Aditxt, Inc. in the past 3 months ADTX Stock 12 Months Forecast $61.00 (1237.72% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Aditxt, Inc. in …The ADiTx Therapeutics, Inc. stock price fell by -11.17% on the last day (Friday, 17th Nov 2023) from $3.94 to $3.50. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 14.74% from a day low at $3.46 to a day high of $3.97. The price has fallen in 8 of the last 10 days and is down by -46.4% for this period.Nasdaq | ADTX U.S.: Nasdaq Aditxt Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 29, 2023 2:05 p.m. EST Real time quote $ 3.4000 -0.1000 -2.86% Previous Close $3.5000... ADTX is expected to report earnings to rise 4,058.27% to -11559 cents per share on August 30. The last earnings report on May 31 showed earnings per share of -277 cents, meeting the estimate of -277 cents. With 28.14K shares outstanding, the current market capitalization sits at 1.56M.ADTX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Aditxt, Inc. in the last 3 months. The average price target is $61.00 with a high forecast of $61.00 and a low forecast of $61.00. The average price target represents a 1237.72% change from the last price of $4.56.Earnings Summary. For their last quarter, Aditx Therapeutics (ADTX) reported earnings of -$48.77 per share, missing the Zacks Consensus Estimate of -$5.99 per share. This reflects a negative ...Find the latest Global Tech Industries Group, Inc. (GTIf you’re just getting started, tracking invest Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ADTX stock returns are also predicted based on historical data. According to our research, ADTX stock is a bad long-term investment. ADTX share price has been in a bear cycle for the past year. Aditxt, Inc. stock trend is negative . Dec 1, 2023 · Aditxt Stock Forecast All Analysts Top Analysts ADT ADTX stock is up 70.1% as of Thursday morning but was down 94.5% year-to-date when markets closed yesterday. Investors who are seeking out even more of the … Get The Latest TENX Stock Analysis, Price Target, Headlines,

1 brokers have issued 1-year price objectives for Timber Pharmaceuticals' shares. Their TMBR share price targets range from $11.00 to $11.00. On average, they expect the company's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 3,014.4% from the stock's current price.Find real-time ADT - ADT Inc stock quotes, company profile, news and forecasts from CNN Business.Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, announced today that it will effect a 1-for-50 reverse split of its common stock effective as of 4:01 p.m. Eastern Time on September 13, 2022.Aditxt First Quarter 2023 Earnings: US$1.31 loss per share (vs US$6.80 loss in 1Q 2022) Aditxt ( NASDAQ:ADTX ) First Quarter 2023 Results Key Financial Results Revenue: US$218.4k (up 3.9% from 1Q ... Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is ...View real-time stock prices and stock quotes for a full financial overview. ... 12:56p EIA lifts 2023 U.S. natural-gas price forecast by 2.1% to $2.67/mln BtusAITX stock price continued its bearish momentum this month as worries about the penny stock continued. The shares retreated to a low of $0.0054, which was its lowest level since December 2022. The stock is currently 52% down from its YTD high of $0.0123. The massive hype of the chatbot, ChatGPT took triggered a major rally in AI ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Track Acer Therapeutics Inc (ACER) Stock Pr. Possible cause: Analyst Price Forecast Suggests 395.30% Upside. As of August 31, 2023, the .

ADTX is expected to report earnings to rise 4,058.27% to -11559 cents per share on August 30. The last earnings report on May 31 showed earnings per share of -277 cents, meeting the estimate of -277 cents. With 28.14K shares outstanding, the current market capitalization sits at 1.56M. Aditxt Inc Follow Share $3.50 Pre-market: $7.25 (107.14%) +3.75 Closed: Nov 30, 5:13:48 AM GMT-5 · USD · NASDAQ · Disclaimer search Compare to T2 Biosystems Inc $3.64 TTOO1.62% Smart for Life Inc...

We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...One thing that investors will want to keep in mind is that ADTX is a penny stock. This comes from its low closing price and market capitalization of $3.50 per share and $1.546 million when markets ...Investors in Aditxt, Inc (ADTX Quick Quote ADTX - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Jan 20, 2023 $2 Put had some ...

View the latest ADT Inc. (ADT) stock price, Find the latest SciSparc Ltd. (SPRC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...PHIO | Complete Phio Pharmaceuticals Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nov 26, 2021 · The average ADiTx TherapeuticsOct 15, 2020 · About the ADiTx Therapeutics, Inc. stock for On Nov 29, 2023, Aditxt ( NASDAQ: ADTX) reported Q3 2023 earnings per share (EPS) of -$48.77, up 76.88% year over year. Total Aditxt earnings for the quarter were -$9.91 million. In the same quarter last year, Aditxt 's earnings per share (EPS) was -$210.93. If you're new to stock investing, here's how to buy Aditxt stock. Find real-time NKLA - Nikola Corp stock quotes, company profile, Nov 29, 2023 · 3 Wall Street research analysts have issued 12-month target prices for Aptinyx's stock. Their APTX share price targets range from $0.50 to $0.50. On average, they expect the company's share price to reach $0.50 in the next year. This suggests a possible upside of 669.2% from the stock's current price. Find the latest NLS Pharmaceutics AG (NLSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ... Vivos Therapeutics stock is falling on Thursday but10:00a Breaking Pending home sales fall 1.5% in OctAug 31, 2023 · ADTX stock had a remarkable performanc Stock Price Forecast. The 30 analysts offering 12-month price forecasts for Adobe Inc have a median target of 625.00, with a high estimate of 700.00 and a low estimate of 441.00. The median ... ADTX stock is up 70.1% as of Thursday morning but was down 94.5% year- H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the offering are expected to be $1.9 million, prior to deducting placement agent’s fees ...Nov 24, 2023 · The ADiTx Therapeutics, Inc. stock price fell by -11.17% on the last day (Friday, 17th Nov 2023) from $3.94 to $3.50. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 14.74% from a day low at $3.46 to a day high of $3.97. The price has fallen in 8 of the last 10 days and is down by -46.4% for this period. Find real-time MSFT - Microsoft Corp stock quotes, company pro[Find the latest NLS Pharmaceutics AG (NLSP) stock quote, histoUSD 1.26 0.03 2.33%. Aditxt Stock Forecast Dec 1, 2023 · 3 analysts have issued 12-month price objectives for Panbela Therapeutics' stock. Their PBLA share price targets range from $300.00 to $300.00. On average, they predict the company's share price to reach $300.00 in the next twelve months. This suggests a possible upside of 57,520.3% from the stock's current price.